3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms, Germ Cell and Embryonal
1
Interventions
Cyclophosphamide
2
sodium thiosulfate
1
repotrectinib
1
pralsetinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
bintrafusp alfa protein, human
1
Thrombopoietin
1
Plicamycin
1
Melphalan
1
Mannitol
1
ICE protocol 5
1
Etoposide
1
Drug Therapy
1
Cytosine Deaminase
1
Carboplatin
1
Bevacizumab
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Neoplasms, Germ Cell and Embryonal
×
ICE protocol 5
×
Clear all
NCT01966913
2019-02-19
TAXIFIII
Assistance Publique - Hôpitaux de Paris
Phase 1/2
Unknown
30 enrolled